Woman and Man
- | Country :
- South Africa
- Poland
- Hungary
- The 8 others...
- | organs : -
- | Specialty : -
Extract
This study is being conducted to confirm the efficacy, safety, and immunogenicity of recombinant human C1 inhibitor (rhC1INH) at a dose of 50 U/kg when used for the treatment of acute angioedema attacks in Hereditary Angioedema (HAE) patients.
Inclusion criteria
- hereditary angioedema